cnbc.comThis little-known health-care stock is trouncing the market and could be worth buying, says Alger’s Amy Zhangabout 1 month ago
cnbc.comThe aging population is a $1 trillion opportunity. These stocks are the winners, says Mizuhoabout 1 month ago
businesswire.comiVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia3 months ago
businesswire.comGlaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 203 months ago
businesswire.comGlaukos Announces Positive Clinical Updates for its iDose Sustained-Release Procedural Pharmaceutical Platform3 months ago
finance.yahoo.comNicox Provides Third Quarter 2024 update and First Half 2024 Financial Results6 months ago
CashuGlaukos Launches iDose: Revolutionary Approach to Glaucoma Management and Ocular Healthabout 1 month ago
CashuGlaukos Set to Thrive Amid Growing Demand from Aging Population and Rising Glaucoma Casesabout 1 month ago